Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
Crossref DOI link: https://doi.org/10.1007/s40744-018-0108-4
Published Online: 2018-04-09
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borse, Rebekah H.
Kachroo, Sumesh
Brown, Chloe
McCann, Eilish
Insinga, Ralph P.
Funding for this research was provided by:
Merck & Co., Inc.
Text and Data Mining valid from 2018-04-09
Article History
Received: 26 January 2018
First Online: 9 April 2018